CH626999A5 - Process for the preparation of a stable erythrocyte preparation - Google Patents
Process for the preparation of a stable erythrocyte preparation Download PDFInfo
- Publication number
- CH626999A5 CH626999A5 CH1417376A CH1417376A CH626999A5 CH 626999 A5 CH626999 A5 CH 626999A5 CH 1417376 A CH1417376 A CH 1417376A CH 1417376 A CH1417376 A CH 1417376A CH 626999 A5 CH626999 A5 CH 626999A5
- Authority
- CH
- Switzerland
- Prior art keywords
- erythrocytes
- chromium
- aldehyde
- antigen
- water
- Prior art date
Links
- 210000003743 erythrocyte Anatomy 0.000 title claims description 64
- 238000002360 preparation method Methods 0.000 title claims description 17
- 238000000034 method Methods 0.000 title claims description 12
- 230000008569 process Effects 0.000 title claims description 3
- 102000036639 antigens Human genes 0.000 claims description 39
- 108091007433 antigens Proteins 0.000 claims description 39
- 239000000427 antigen Substances 0.000 claims description 37
- 239000000725 suspension Substances 0.000 claims description 17
- 239000000243 solution Substances 0.000 claims description 16
- 150000001844 chromium Chemical class 0.000 claims description 14
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 claims description 10
- 239000011248 coating agent Substances 0.000 claims description 10
- 238000000576 coating method Methods 0.000 claims description 10
- 229910052804 chromium Inorganic materials 0.000 claims description 9
- 239000011651 chromium Substances 0.000 claims description 9
- 150000003839 salts Chemical class 0.000 claims description 7
- 229910021556 Chromium(III) chloride Inorganic materials 0.000 claims description 6
- -1 aliphatic aldehyde Chemical class 0.000 claims description 6
- 239000011636 chromium(III) chloride Substances 0.000 claims description 6
- QSWDMMVNRMROPK-UHFFFAOYSA-K chromium(3+) trichloride Chemical compound [Cl-].[Cl-].[Cl-].[Cr+3] QSWDMMVNRMROPK-UHFFFAOYSA-K 0.000 claims description 5
- 235000007831 chromium(III) chloride Nutrition 0.000 claims description 5
- 239000007864 aqueous solution Substances 0.000 claims description 4
- 229910021554 Chromium(II) chloride Inorganic materials 0.000 claims description 3
- 241000223996 Toxoplasma Species 0.000 claims description 3
- 241000589884 Treponema pallidum Species 0.000 claims description 3
- XBWRJSSJWDOUSJ-UHFFFAOYSA-L chromium(ii) chloride Chemical compound Cl[Cr]Cl XBWRJSSJWDOUSJ-UHFFFAOYSA-L 0.000 claims description 3
- 239000008291 lyophilic colloid Substances 0.000 claims description 2
- 125000002485 formyl group Chemical class [H]C(*)=O 0.000 claims 4
- 230000002378 acidificating effect Effects 0.000 claims 1
- 125000004432 carbon atom Chemical group C* 0.000 claims 1
- 239000000644 isotonic solution Substances 0.000 claims 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 17
- 150000001299 aldehydes Chemical class 0.000 description 13
- 230000035931 haemagglutination Effects 0.000 description 9
- 239000003153 chemical reaction reagent Substances 0.000 description 8
- 210000004027 cell Anatomy 0.000 description 7
- 210000002966 serum Anatomy 0.000 description 7
- AIJULSRZWUXGPQ-UHFFFAOYSA-N Methylglyoxal Chemical compound CC(=O)C=O AIJULSRZWUXGPQ-UHFFFAOYSA-N 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 6
- 239000013049 sediment Substances 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 239000007975 buffered saline Substances 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 239000011780 sodium chloride Substances 0.000 description 5
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- 241000283973 Oryctolagus cuniculus Species 0.000 description 3
- 239000006285 cell suspension Substances 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000003381 stabilizer Substances 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 241000287828 Gallus gallus Species 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000004520 agglutination Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 239000008098 formaldehyde solution Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 239000002953 phosphate buffered saline Substances 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 244000144977 poultry Species 0.000 description 2
- 238000004062 sedimentation Methods 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- YWOPZILGDZKFFC-DFWYDOINSA-M sodium;(2s)-2,5-diamino-5-oxopentanoate Chemical compound [Na+].[O-]C(=O)[C@@H](N)CCC(N)=O YWOPZILGDZKFFC-DFWYDOINSA-M 0.000 description 2
- 210000001550 testis Anatomy 0.000 description 2
- 238000002604 ultrasonography Methods 0.000 description 2
- WXHLLJAMBQLULT-UHFFFAOYSA-N 2-[[6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl]amino]-n-(2-methyl-6-sulfanylphenyl)-1,3-thiazole-5-carboxamide;hydrate Chemical compound O.C=1C(N2CCN(CCO)CC2)=NC(C)=NC=1NC(S1)=NC=C1C(=O)NC1=C(C)C=CC=C1S WXHLLJAMBQLULT-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 241000271566 Aves Species 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 102000004506 Blood Proteins Human genes 0.000 description 1
- 108010017384 Blood Proteins Proteins 0.000 description 1
- 229920000298 Cellophane Polymers 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 241000272201 Columbiformes Species 0.000 description 1
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 241000978776 Senegalia senegal Species 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 230000005784 autoimmunity Effects 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 210000003855 cell nucleus Anatomy 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 239000007857 degradation product Substances 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 239000012470 diluted sample Substances 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 229940120731 pyruvaldehyde Drugs 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000013517 stratification Methods 0.000 description 1
- 208000006379 syphilis Diseases 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/554—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being a biological cell or cell fragment, e.g. bacteria, yeast cells
- G01N33/555—Red blood cell
- G01N33/556—Fixed or stabilised red blood cell
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/10—Preservation of living parts
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/10—Preservation of living parts
- A01N1/12—Chemical aspects of preservation
- A01N1/122—Preservation or perfusion media
- A01N1/125—Freeze protecting agents, e.g. cryoprotectants or osmolarity regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/18—Erythrocytes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Cell Biology (AREA)
- Hematology (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Urology & Nephrology (AREA)
- Environmental Sciences (AREA)
- Wood Science & Technology (AREA)
- Dentistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Physics & Mathematics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Developmental Biology & Embryology (AREA)
- Mycology (AREA)
- Virology (AREA)
- Food Science & Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2551208A DE2551208C3 (de) | 1975-11-14 | 1975-11-14 | Verfahren zur Herstellung einer stabilen Erythrozyten-Präparation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH626999A5 true CH626999A5 (en) | 1981-12-15 |
Family
ID=5961771
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH1417376A CH626999A5 (en) | 1975-11-14 | 1976-11-10 | Process for the preparation of a stable erythrocyte preparation |
Country Status (18)
| Country | Link |
|---|---|
| JP (1) | JPS5261218A (cs) |
| AR (1) | AR213420A1 (cs) |
| AT (1) | AT356812B (cs) |
| AU (1) | AU511427B2 (cs) |
| BE (1) | BE848377A (cs) |
| BR (1) | BR7607564A (cs) |
| CH (1) | CH626999A5 (cs) |
| DE (1) | DE2551208C3 (cs) |
| DK (1) | DK146138C (cs) |
| ES (1) | ES453136A1 (cs) |
| FR (1) | FR2331352A1 (cs) |
| GB (1) | GB1563839A (cs) |
| IE (1) | IE44471B1 (cs) |
| IT (1) | IT1063992B (cs) |
| LU (1) | LU76194A1 (cs) |
| MX (1) | MX3937E (cs) |
| NL (1) | NL189133C (cs) |
| SE (1) | SE431800B (cs) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2828820A1 (de) * | 1977-08-01 | 1979-02-08 | Warner Lambert Co | Verfahren zur herstellung einer stabilen blutplaettchensuspension und nach dem verfahren erhaltene stabile blutplaettchensuspension |
| US4302355A (en) * | 1977-08-01 | 1981-11-24 | Warner-Lambert Company | Platelet reference control |
| JPS5917388B2 (ja) * | 1979-02-22 | 1984-04-20 | 富士レビオ株式会社 | 間接凝集反応用吸収剤 |
| EP0039195B1 (en) * | 1980-04-28 | 1986-06-18 | Montefiore Hospital and Medical Center | Antibody detection process |
| GB2138132B (en) * | 1983-04-12 | 1987-02-18 | Robin Royston Amos Coombs | Storage-stable antibody-linked erythrocytes |
| JPS6161055A (ja) * | 1984-08-31 | 1986-03-28 | Shionogi & Co Ltd | ウイルス赤血球凝集反応試験用鳥類固定赤血球の保存液 |
| DE3501496A1 (de) * | 1985-01-18 | 1986-07-24 | Behringwerke Ag, 3550 Marburg | Verfahren zur bestimmung der aktivitaet des komplementsystems des blutes |
| FR2617185B1 (fr) * | 1987-06-25 | 1990-03-09 | Fondation Nale Transfusion San | Procede de stabilisation de membranes cellulaires et son app lication a la conservation des cellules sous une forme protegeant l'essentiel de leurs antigenes de surface |
| US5079173A (en) * | 1987-08-19 | 1992-01-07 | Shionogi & Co., Ltd. | Methods, hybridomas, monoclonal antibodies and sensitized cells for measuring hbs antigen |
| JPH01107154A (ja) * | 1987-10-20 | 1989-04-25 | Seitetsu Kagaku Co Ltd | 加工赤血球およびその製造方法 |
| US5045446A (en) * | 1988-08-26 | 1991-09-03 | Cryopharm Corporation | Lyophilization of cells |
| IL90188A0 (en) * | 1988-05-18 | 1989-12-15 | Cryopharm Corp | Process and medium for the lyophilization of erythrocytes |
| EP0356258A3 (en) * | 1988-08-26 | 1990-06-06 | Cryopharm Corporation | Processes for the lyophilization of red blood cells, together with media for lyophilization |
| US5059518A (en) * | 1988-10-20 | 1991-10-22 | Coulter Corporation | Stabilized lyophilized mammalian cells and method of making same |
| DE69128782T2 (de) * | 1990-04-24 | 1998-09-10 | Flustat Pty Ltd | Oraler an der oberfläche von erythrozyten gebundene antigene beinhaltender impfstoff |
| US5882649A (en) * | 1990-04-24 | 1999-03-16 | Flustat Pty. Ltd. | Oral vaccine comprising antigen surface-associated with red blood cells |
| EP0721104A2 (en) * | 1993-07-05 | 1996-07-10 | Northern General Hospital N.H.S. Trust | Preparation and stabilisation of cells |
| US6197540B1 (en) * | 1993-07-05 | 2001-03-06 | Northern General Hospital N.H.S. Trust | Preparation and stabilization of cells using aged transition metal solutions |
| CA2187196A1 (en) * | 1994-04-05 | 1995-10-12 | Northern General Hospital N.H.S. Trust | Preparation and stabilisation of cell suspensions |
| GB2313288B (en) | 1996-05-24 | 2000-07-12 | North Gen Hospital Nhs Trust | Specimen collection fluid |
| CN100376669C (zh) | 2005-02-25 | 2008-03-26 | 深圳迈瑞生物医疗电子股份有限公司 | 生物红细胞体积长期稳定的处理方法 |
| CN111295094A (zh) | 2017-10-09 | 2020-06-16 | 泰尔茂比司特生物技术有限公司 | 冻干容器及使用冻干容器的方法 |
| KR20240161711A (ko) * | 2018-03-27 | 2024-11-12 | 이그잭트 사이언시즈 코포레이션 | 헤모글로빈 안정화 방법 및 동일한 수행을 위한 시약 |
| CA3130668A1 (en) | 2019-03-14 | 2020-12-03 | Terumo Bct Biotechnologies, Llc | Multi-part lyophilization container and method of use |
| FR3121577B1 (fr) | 2021-04-12 | 2024-03-08 | Elitech Microbio | Composition stabilisante, procédé utilisant ladite composition pour la fabrication de produits de contrôle d’analyses de prélèvements biologiques chez les mammifères, et produits de contrôle issus de la mise en œuvre dudit procédé |
| CN115399314B (zh) * | 2022-11-01 | 2023-05-19 | 天津德祥生物技术股份有限公司 | 一种能冻干保存的人abo血型反定型红细胞及保存方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL293434A (cs) * | 1962-02-05 | |||
| FR1521350A (fr) * | 1965-09-10 | 1968-04-19 | Princeton Lab | Détection de la mononucléose |
| GB1244344A (en) * | 1967-11-13 | 1971-08-25 | Abbott Lab | Hemagglutination testing procedure employing stabilized and potentiated erythrocytes and a method for their preparation |
| DE2025718C3 (de) * | 1967-11-13 | 1979-06-13 | Abbott Laboratories, Chicago, Ill. (V.St.A.) | Verfahren zum Stabilisieren von lyophillsierten Erythrozyten |
| FR2233024A1 (en) * | 1973-06-15 | 1975-01-10 | Greyward Lab Interconti | Treponema haemagglutination test - using tanned avian erythrocytes as carrier for ireponema antigen |
-
1975
- 1975-11-14 DE DE2551208A patent/DE2551208C3/de not_active Expired
-
1976
- 1976-11-09 ES ES453136A patent/ES453136A1/es not_active Expired
- 1976-11-09 NL NLAANVRAGE7612439,A patent/NL189133C/xx not_active IP Right Cessation
- 1976-11-10 CH CH1417376A patent/CH626999A5/de not_active IP Right Cessation
- 1976-11-11 SE SE7612622A patent/SE431800B/xx not_active IP Right Cessation
- 1976-11-12 IT IT29315/76A patent/IT1063992B/it active
- 1976-11-12 AR AR265448A patent/AR213420A1/es active
- 1976-11-12 DK DK510976A patent/DK146138C/da not_active IP Right Cessation
- 1976-11-12 IE IE2494/76A patent/IE44471B1/en not_active IP Right Cessation
- 1976-11-12 AU AU19588/76A patent/AU511427B2/en not_active Expired
- 1976-11-12 GB GB47221/76A patent/GB1563839A/en not_active Expired
- 1976-11-12 LU LU76194A patent/LU76194A1/xx unknown
- 1976-11-12 BR BR7607564A patent/BR7607564A/pt unknown
- 1976-11-12 MX MX765121U patent/MX3937E/es unknown
- 1976-11-12 AT AT843476A patent/AT356812B/de not_active IP Right Cessation
- 1976-11-13 JP JP51135855A patent/JPS5261218A/ja active Granted
- 1976-11-15 FR FR7634332A patent/FR2331352A1/fr active Granted
- 1976-11-16 BE BE172391A patent/BE848377A/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| ES453136A1 (es) | 1978-01-16 |
| DK510976A (da) | 1977-05-15 |
| AU511427B2 (en) | 1980-08-21 |
| SE7612622L (sv) | 1977-05-15 |
| IE44471L (en) | 1977-05-14 |
| IT1063992B (it) | 1985-02-18 |
| FR2331352B1 (cs) | 1982-07-09 |
| DE2551208A1 (de) | 1977-05-26 |
| JPS616941B2 (cs) | 1986-03-03 |
| AU1958876A (en) | 1978-05-18 |
| AT356812B (de) | 1980-05-27 |
| GB1563839A (en) | 1980-04-02 |
| FR2331352A1 (fr) | 1977-06-10 |
| NL189133B (nl) | 1992-08-17 |
| DK146138C (da) | 1983-11-28 |
| DE2551208C3 (de) | 1981-05-27 |
| MX3937E (es) | 1981-10-02 |
| ATA843476A (de) | 1979-10-15 |
| SE431800B (sv) | 1984-02-27 |
| DE2551208B2 (de) | 1980-09-11 |
| NL189133C (nl) | 1993-01-18 |
| BE848377A (fr) | 1977-05-16 |
| LU76194A1 (cs) | 1977-06-06 |
| AR213420A1 (es) | 1979-01-31 |
| DK146138B (da) | 1983-07-04 |
| BR7607564A (pt) | 1977-09-27 |
| IE44471B1 (en) | 1981-12-16 |
| JPS5261218A (en) | 1977-05-20 |
| NL7612439A (nl) | 1977-05-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CH626999A5 (en) | Process for the preparation of a stable erythrocyte preparation | |
| DE69121849T2 (de) | Bindung von Liganden an Gold | |
| DE2902677C2 (cs) | ||
| DE2546166A1 (de) | Gegerbte thrombozyten | |
| DE2322562C2 (de) | Verfahren zur Bestimmung von Antigenen in einer Probe | |
| CH631266A5 (de) | Diagnostisches mittel. | |
| DE2523207A1 (de) | Verfahren zur bestimmung von antikoerpern | |
| EP0379133B1 (de) | Verwendung von zweiwertigen Kationen in immunchemischen Tests | |
| DE3338759C1 (de) | Verfahren zum stabilen Binden von proteinischen Antigenen oder Allergenen an feste Traeger | |
| DE2025718C3 (de) | Verfahren zum Stabilisieren von lyophillsierten Erythrozyten | |
| DE2712044A1 (de) | Stabile immunologische reagenzien | |
| CH645727A5 (de) | Praeparat zur bestimmung von menschlichem beta-2-mikroglobulin, verfahren zu seiner herstellung und seine verwendung. | |
| DE1617734B1 (de) | Verfahren zur Herstellung eines immunologischen Reagens | |
| CH646259A5 (de) | Diagnostisches mittel zur bestimmung eines antigens. | |
| DE2551576B2 (de) | Traeger fuer immunochemische messungen | |
| AT364091B (de) | Durchfuehrung eines haemagglutinationstests | |
| DE2850950B2 (de) | Verwendung von nativem oder thermisch modifiziertem Cytochrom c als Stabilisator für ein immunochemisches Meßreagens, immunochemisches Meflreagens sowie Pufferlösung zur Probenverdünnung bei immunchemischen Meßverfahren | |
| EP0011716A1 (de) | Reagenz zum Nachweis von infektiöser Mononucleose und Verfahren zu seiner Herstellung | |
| DE3638767A1 (de) | Laktoferrin enthaltendes inkubationsmedium fuer festphasenimmunometrisches verfahren und seine verwendung | |
| DE3024270A1 (de) | Masse zur bestimmung von menschlichem erythropoietin und deren anwendung | |
| DE1617666A1 (de) | Verfahren zur Herstellung von Erythrozyten-Praeparaten | |
| DE2703668C2 (de) | Verfahren zur Messung der Menge an Schilddrüsenhormon in einer Serumprobe | |
| DE1598859C (de) | Verfahren zur Herstellung von Reagen zien für immunochemische Bestimmungen | |
| DE1808435C3 (de) | Verfahren zum Stabilisieren von Erythrozyten | |
| DE1954728A1 (de) | Blutagglutination-Inhibierungstest fuer Viren |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PL | Patent ceased |